December 30, 2024 Positrigo looks back on a successful year with numerous achieved milestones
October 2, 2024 Positrigo secures CE Mark in Europe for NeuroLF System
July 16, 2024 NeuroLF now FDA cleared and available for sale in the US.
April 4, 2024 First brain images from the NeuroLF system were presented at the ECCN conference.
October 16, 2023 Positrigo opens US subsidiary to benefit from promising market developments
September 13, 2023 Unveiling of NeuroLF System at EANM 2023 in Vienna
June 8, 2023 Positrigo appoints Prof. Simon Cherry as Advisory Board member and reports preliminary performance data of NeuroLF
May 3, 2023 Positrigo receives Swiss Accelerator grant from Innosuisse
December 29, 2022 Positrigo reflects on a successful Year.
December 21, 2022 Positrigo team co-authors proof-of-concept study
This website uses cookies to provide services and analyze access. read more
United States of America Other countries (English) Other countries (German)